Which treatment is specifically indicated for patients with Kawasaki disease?

High-dose aspirin is specifically indicated for patients with Kawasaki disease due to its anti-inflammatory properties and its role in preventing thromboembolic complications. Kawasaki disease is characterized by systemic vasculitis that primarily affects children and can lead to serious cardiovascular complications, including coronary artery aneurysms. High-dose aspirin helps reduce inflammation and fever during the acute phase of the illness. Additionally, it has antiplatelet effects that are crucial in preventing thrombosis in the inflamed arteries.

While low-dose steroids, antibiotics, and vasodilators may have their own roles in other conditions or in specific scenarios, they are not standard treatments for Kawasaki disease itself. Low-dose steroids may be used in certain cases, but they are not first-line therapy. Antibiotics are ineffective against the underlying vasculitis since Kawasaki disease is not caused by a bacterial infection. Vasodilators are typically utilized in other cardiovascular conditions but do not address the core issues presented in Kawasaki disease. Thus, high-dose aspirin stands out as the cornerstone of treatment in managing Kawasaki disease.